Baraitser P, Pearce V, Holmes J, Horne N, Boynton P M
Lambeth and Southwark Sexual Health Modernisation Programme, London, UK.
Qual Saf Health Care. 2007 Aug;16(4):303-7. doi: 10.1136/qshc.2006.020883.
Chlamydia trachomatis infection is a common sexually transmitted infection with serious sequelae. Excellent access to testing, treatment and contact tracing are an essential part of strategies to control it. With traditional sexual health services over-stretched, community pharmacies are well placed to provide this service. They have the potential to improve access by offering chlamydia testing and treatment from high street venues with long opening hours. This study evaluated the feasibility and acceptability to users and pharmacists of this service in independent community pharmacies.
A chlamydia testing and treatment service was offered in three community pharmacies in two inner London boroughs for a 3-month pilot. Data on the feasibility and acceptability of the new service were collected via a survey of client experience, in-depth semistructured interviews with clients and pharmacists, and structured evaluation reports completed by professional patients paid to visit the pharmacies.
83 tests were taken with eight (9.5%) of these positive for C trachomatis. Of those tested, 94% (n = 73) were women and 71% (n = 56) were from ethnic minorities. 80 clients completed the questionnaires and 24 clients were interviewed. Most clients heard about the service from the pharmacist when requesting emergency contraception and 16% (n = 13) would not otherwise have been tested. Clients valued the speed and convenience of the service and the friendly, non-judgmental approach of the pharmacist. Confidentiality when asking for the service at the counter was suboptimal, and the pharmacist trained to deliver the service was not always available to provide it.
Chlamydia testing and treatment in community pharmacies is feasible and acceptable to users. The service increases access among young women at high risk of sexually transmitted infection but not among young men.
沙眼衣原体感染是一种常见的性传播感染，可导致严重后遗症。良好的检测、治疗及接触者追踪途径是控制该疾病策略的重要组成部分。由于传统性健康服务不堪重负，社区药房具备提供此项服务的优势。它们有潜力通过在营业时间长的商业街场所提供衣原体检测和治疗来改善服务可及性。本研究评估了在独立社区药房开展此项服务对用户和药剂师的可行性及可接受性。
在伦敦市中心两个行政区的三家社区药房提供为期3个月的衣原体检测和治疗试点服务。通过对客户体验的调查、对客户和药剂师的深入半结构化访谈以及由受雇前往药房的专业患者完成的结构化评估报告，收集有关新服务可行性和可接受性的数据。
共进行了83次检测，其中8例（9.5%）沙眼衣原体呈阳性。在接受检测者中，94%（n = 73）为女性，71%（n = 56）来自少数民族。80名客户完成了问卷调查，24名客户接受了访谈。大多数客户在要求紧急避孕时从药剂师处得知该服务，16%（n = 13）的人否则不会接受检测。客户重视该服务的速度和便利性以及药剂师友好、无偏见的态度。在柜台询问该服务时的保密性欠佳，且接受过提供该服务培训的药剂师并非总能提供服务。
社区药房的衣原体检测和治疗对用户来说是可行且可接受的。该服务增加了性传播感染高危年轻女性的检测机会，但未增加年轻男性的检测机会。
